INDEPTH Network
  • Contact Us
  • Login
  • Logo
    • Home
    • What is this?
    • How to use it?
    • History
    • Data
    • Citations
    • News
    • INDEPTHStats
    • Acknowledgements
    • Feedback


    South Africa - Participation in Africa Centre's HIV surveillance between 2003 and 2012

    HIV-Surveillance-Africa
    Reference ID AC.HIV.Participation.2003.2012
    Year 2002 - 2005
    Country South Africa
    Producer(s) Dr Kobus Herbst - Africa Centre
    Dr Till Barnighausen - Africa Centre
    Mr Tinofa Mutevedzi - Africa Centre
    Mr Dickman Gareta - Africa Centre
    Sponsor(s) Wellcome Trust - WT - funder
    Collection(s)
    Participation in Africa Centre's HIV surveillance between 2003 and 2012
    Metadata PDF Documentation in PDF
    Created on
    Feb 25, 2015
    Last modified
    Feb 25, 2015
    Page views
    95019
    • Study Description
    • Data Dictionary
    • Get Microdata
    • Overview
    • Sampling
    • Data Collection
    • Access policy
    • Export Metadata
    Data Collection
    Data Collection Dates
    StartEndCycle
    2002-112005-02Round 2003/2004
    2006-012006-02Round 2006
    2007-012007-02Round 2007
    2008-012008-12Round 2008
    2009-012009-12Round 2009
    2010-012010-12Round 2010
    2011-012011-12Round 2011
    2012-012012-12Round 2012
    Time Periods
    StartEndCycle
    2002-11Data Collection
    Data Collection Mode
    Face-to-face [f2f]
    Data Collection Notes

    For data collected as part of the HIV sero-survey, teams of two trained fieldworkers visit each eligible individual in his or her household on an annual basis. If a subject is absent, the field workers make up to four repeat visits to the same household. If a subject no longer lives in the household, the field worker hands the case to a specially trained tracking team that attempts to find the individual in his or her new residence which may be as far as Johannesburg or Durban. After written informed consent, field workers collect blood by finger prick and prepare dried blood spots for HIV testing according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) Guidelines for Using HIV Testing Technologies in Surveillance. HIV status is determined by antibody testing with a broad-based HIV-1/HIV-2 ELISA (Vironostika HIV-1 Microelisa System Biome´rieux, Durham, NC, USA) followed by a confirmatory ELISA (Wellcozyme HIV 1þ2 GACELISA; Murex Diagnostics Benelux B.V., Breukelen, The Netherlands). HIV test results can be obtained confidentially in a number of counselling centres which have been set up for that purpose in the survey area.

      Logo
    Logo

    ©2013 INDEPTH Network, All Rights Reserved